Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Homeobox and leucine zipper protein Homez (HOMEZ) is a vertebrate transcription factor that encodes a protein with an unusual structure, including three atypical homeodomains and two leucine zipper-like motifs, as well as an acidic domain[1][2][3]. It is ubiquitously expressed in human and mouse tissues, though expression is more restricted during mouse development[1]. HOMEZ binds DNA and likely functions as a transcriptional regulator, either activating or repressing gene expression via its homeodomains and leucine zipper domains, and has been classified as a member of a distinct subset of homeodomain-containing proteins along with members of the ZHX family[1][2][3][6]. Currently, there is no evidence that HOMEZ is a direct therapeutic target or that any drugs interact with it. Some genetic associations exist with rare syndromes (such as Joubert syndrome 18 and Ebstein anomaly)[3], but its precise roles in disease are not well characterized.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Homeobox and leucine zipper protein Homez (HOMEZ).